The 2nd edition of the Networking & Innovation Day (NID) will take place tomorrow (Thursday) at the PCB. Its objective is to create a benchmark in knowledge transfer between academia and business that promotes public-private collaboration, partnership agreements and open innovation.
Today is the first day of the annual congress of the Sociedad Española de Ingeniería Biomédica (CASEIB 2014) which this year being organized by IBEC, as Biomedical Signal Processing and Interpretation group leader Raimon Jané is SEIB’s president. It is taking take place at Barcelona’s CosmoCaixa museum until Friday 28th November.
Saturday saw the inauguration of the exhibition “Curar-se en salut” at the Museu d’Història de Sant Feliu de Guíxols, an initiative of the town’s council with the involvement of two CERCA centres, IBEC and Girona’s Institut d’Investigació Biomèdica (IDIBGi), among other bodies. The vice-president of the Government of Catalonia, Joana Ortega i Alemany, and Minister of Health Boi Ruiz i Garcia were in attendance at the unveiling.
This week the NanoBio&Med 2014 international conference, co-organised and sponsored by IBEC, is taking place in Barcelona. The four-day event aims to cover current research and recent developments in the fields of nanobiotechnology and nanomedicine.
Awarded biennially by the CIBER-BBN-Young Scientist Forum in Biomaterials, the prize recognizes, encourages and stimulates outstanding research contributions to the field of biomaterials by young scientists working in Spanish institutions who incorporate an international dimension and perspective into their research.
The Fundación Española para la Ciencia y la Tecnología (FECYT) received 881 proposals from 383 public and private organisations for the call, which offers a total funding pot of €3,25 million for ideas and activities aimed at the promotion of scientific culture, technology and innovation.
IBEC’s Molecular and Cellular Neurobiotechnology group is to receive funding from 2013’s La Marató de TV3 for their project “Role of the cellular prion protein as “cross-talk” protein between a-syn/ LRRK2 and p-Tau in sporadic and familiar Parkinson´s disease.”The group’s proposal was one of 44 selected for funding under the annual award, which in its 2013 call focused on neurodegenerative diseases.
Not only that, but the institute was ranked top among the applicants, meaning it will receive one of the two largest portions of the total grant money, the other going to the ISCIII.
Tomorrow night IBEC group leader and ICREA professor Ángel Raya will give a public lecture at the CCCB in Barcelona entitled “Células madre y medicina regenerativa: realidades y promesas” (“Stem cells and regenerative medicine: realities and promises”). Ángel, who is also director of the Barcelona Centre for Regenerative Medicine (CMRB), is contributing the lecture as part of the fourth ICREA-CCCB Debates series, taking place from 21 October to 11 November, which this year is devoted to “Stem Cells: a Future without Diseases?”.
IBEC’s Core Facilities have been included in MINECO’s updated ICTS (Infraestructuras Científicas y Técnicas Singulares) map as part of NANBIOSIS, an integrated platform for research-oriented medical applications. Created by combining the service platforms within the CIBER-BBN and CCMIJU (the Center for Minimally Invasive Surgery Jesus Uson), NANBIOSIS (Infraestructuras Integrada de Producción y Caracterización de Nanomateriales, Biomateriales y Sistemas en Biomedicina) aims to be a ‘one-stop-shop’ service facility for the design and production of biomaterials and nanomaterials, among other applications.